Exagen Inc expected to post a loss of 61  cents a share - Earnings Preview

Exagen

10/05/2022 03:04

* Exagen Inc  XGN.OQ   XGN.O  is expected to show a fall in
quarterly revenue when it reports  results on May 11. 
    * The Vista California-based  company is expected to report 
a
5.5% decrease in revenue to $10 million from $10.59 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Exagen Inc is for a
loss
of 61 cents per share. For the same quarter last year, the
company reported a loss of 48 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Exagen Inc
is
$19​, above​ its last closing price of $5.95. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.44       -0.50      -0.42     Beat    15.4
 Sep. 30 2021  -0.47       -0.46      -0.42     Beat    8.7
 Jun. 30 2021  -0.47       -0.44      -0.38     Beat    13​
 Mar. 31 2021  -0.47       -0.47      -0.48     Missed  -2.3
 ​​Dec.        -0.38       -0.41      -0.27     Beat    33.4
 31 2020                                                
 Sep. 30 2020  -0.47       -0.47      -0.34     Beat    28.4​
 Jun. 30 2020  -0.75       -0.76      -0.27     Beat    64.4
 Mar. 31 2020  -0.48       -0.49      -0.44     Beat    10.2
 This summary was machine generated May 10 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated